[{"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0238-2024", "product_description": "Old Spice, PURE SPORT, (Aluminum Chlorohydrate 23.5%),  Anti-Perspirant & Deodorant Spray, Topical spray can, Net WT 6.0 OZ (170g), Distributed by Procter & Gamble, Cincinnati, OH 45202.  NDC: 37000-199-60, UPC 0 12044 00191 2", "product_quantity": "unknown", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "Lot #: 11661458SM, 11681458SB, Exp 5/31/23; 12621458SV, 12631458SB, Exp 08/31/23"}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0380-2024", "product_description": "TRP Natural Eyes Floaters Relief, Sterile Eye Drops, 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-098-15.", "product_quantity": "24,216 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: F404, Exp: 05-14-2025, F405, Exp: 08-24-2025, F406, Exp: 10-11-2026."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0192-2024", "product_description": "Nyamyc, 100,000 USP units per gram,  60 grams, Rx only, Topical Use Only, Manufactured by: Upsher-Smith Laboratories, Inc, Minneapolis, MN 55447.", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 400454", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA086242"], "brand_name": ["HYDRALAZINE HYDROCHLORIDE"], "generic_name": ["HYDRALAZINE HYDROCHLORIDE"], "manufacturer_name": ["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."], "product_ndc": ["23155-001", "23155-002", "23155-003", "23155-004"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDRALAZINE HYDROCHLORIDE"], "rxcui": ["905199", "905222", "905225", "905395"], "spl_id": ["55cf4bfc-8b55-499f-9aa1-c0cd8ec454d8"], "spl_set_id": ["a04eefaf-ba3c-448d-8ece-4aa9ab2e3508"], "package_ndc": ["23155-001-01", "23155-001-10", "23155-002-10", "23155-002-01", "23155-003-01", "23155-003-10", "23155-004-01", "23155-004-10"], "is_original_packager": [true], "upc": ["0323155002010", "0323155001013", "0323155004014", "0323155003017"], "unii": ["FD171B778Y"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0184-2024", "product_description": "HydrALAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816.  NDC: 23155-002-01", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch G210553, G210551", "more_code_info": ""}, {"status": "Completed", "city": "Mooresville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93869", "recalling_firm": "Bestco LLC", "address_1": "288 Mazeppa Rd", "address_2": "N/A", "postal_code": "28115-7928", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0332-2024", "product_description": "Equate Cherry Cough Drops, Menthol cough suppressant/Oral Anesthetic, a) 30 drops per bag, item number 20000462, b) 160 drops per bag, item number 20000463, Bestco, 288 Mazeppa Road, Mooresville, NC 28115", "product_quantity": "a) 1597 cases/ 12 pack each b) 73 cases/4 pack each", "reason_for_recall": "CGMP Deviations: Potential Glass and Silicone particulates in product", "recall_initiation_date": "20240119", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "a) 100041954, Exp 12/31/2026;  b) 100042048, 100042060, Exp 12/31/2026"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0304-2024", "product_description": "LUBRICANT EYE DROPS (Carboxymethylcellulose Sodium 0.5%), packaged 0.5 FL OZ (15mL) bottles (Twin Pack), Distributed by: Rite Aid 30 Hunter Lane, Camp Hill, PA 17011, NDC 11822-4811-5", "product_quantity": "6,024 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M005"], "brand_name": ["MEDLINE"], "generic_name": ["MICONAZOLE NITRATE"], "manufacturer_name": ["Medline Industries, LP"], "product_ndc": ["53329-147"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["MICONAZOLE NITRATE"], "rxcui": ["998483"], "spl_id": ["41edd027-d6ee-ca16-e063-6394a90a3d32"], "spl_set_id": ["0d997d1d-8663-201f-e063-6394a90a285e"], "package_ndc": ["53329-147-44"], "is_original_packager": [true], "unii": ["VW4H1CYW1K"]}, "product_type": "Drugs", "event_id": "93846", "recalling_firm": "MEDLINE INDUSTRIES, LP - Northfield", "address_1": "3 Lakes Dr", "address_2": "", "postal_code": "60093-2753", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0315-2024", "product_description": "Medline Remedy Clinical TREAT Antifungal Cream, 2% Miconazole Nitrate, Paraben Free, 4 FL OZ (118 mL) tube, Manufactured for Medline Industries, LP Three Lakes Drive, Northfield, IL 60093.  NDC:  53329-147-44", "product_quantity": "1,786 tubes", "reason_for_recall": "Labeling: Not Elsewhere Classified; Product labeling contains the claim of 'Paraben Free' while the product does in fact contain parabens as part of the formulation/ ingredient list.", "recall_initiation_date": "20240110", "center_classification_date": "20240206", "report_date": "20240214", "code_info": "Lot #s: 08926; 08926A Exp. 8/2025; 08928 Exp. 9/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0292-2024", "product_description": "CVS Health brand Lubricant Eye Drops (Propylene glycol 0.6%), packaged in a) 0.33 FL OZ (10mL) bottles (Single Pack) (NDC 76168-714-10) and b) 0.33 FL OZ (10 mL) bottles (Twin pack) (NDC 76168-714-20), Distributed by: CVS Pharmacy Inc. One CVS Drive Woonsocket, RI 02895.", "product_quantity": "137,784 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0174-2024", "product_description": "Colgate Total SF Toothpaste, Net Wt 4.8 oz (136 g), Stannous Fluoride 0.454%, Clean Mint, Dist. by: COLGATE-PALMOLIVE CO., New York, NY 10022 USA", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 1293US561C", "more_code_info": ""}, {"status": "Ongoing", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "93960", "recalling_firm": "Stason Pharmaceuticals, Inc.", "address_1": "11 Morgan", "address_2": "", "postal_code": "92618-2005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0367-2024", "product_description": "Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com", "product_quantity": "54, 131 bottles", "reason_for_recall": "Failed Dissolution Specifications: results slightly under spec at at 9-months.", "recall_initiation_date": "20240209", "center_classification_date": "20240306", "report_date": "20240313", "code_info": "Lot #: a)22K012, 22K013A, Exp: 04/30/2024; 23A001, 23A002A, Exp: 07/31/2024; 23D006, 23D007A, 23D007C, Exp:10/31/2024; b)22K013B, Exp: 04/30/2024; 23A002B, Exp:07/31/2024; 23D007B, Exp: 10/31/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Rosenberg", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93986", "recalling_firm": "Seatex LLC", "address_1": "445 Highway 36 N", "address_2": "", "postal_code": "77471-8756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0359-2024", "product_description": "7 Eleven Hand Sanitizer Gel, Ethanol 70% v/v Antiseptic, Mountain Spring Scent, 1250 mL cases, Magnus 16005 Gateway Drive, Ste 300, Frisco, TX 75033", "product_quantity": "1,282 cases", "reason_for_recall": "CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.", "recall_initiation_date": "20240219", "center_classification_date": "20240229", "termination_date": "20250815", "report_date": "20240306", "code_info": "Lot #s: 266029, Exp. 03/27/2024; 255917, Exp. 06/23/2024; 261521, Exp. 06/27/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Sarasota", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93847", "recalling_firm": "OMEZA LLC", "address_1": "1610 Northgate Blvd", "address_2": "", "postal_code": "34234-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "US Nationwide", "recall_number": "D-0289-2024", "product_description": "Omeza Skin Protectant, Skin Protectant Gel 10*2mL Vials", "product_quantity": "1210 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240119", "center_classification_date": "20240204", "termination_date": "20241017", "report_date": "20240214", "code_info": "Lot:  19123 4-1, Exp. 05/11/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022231"], "brand_name": ["TERLIVAZ"], "generic_name": ["TERLIPRESSIN"], "manufacturer_name": ["Mallinckrodt Hospital Products Inc."], "product_ndc": ["43825-200"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TERLIPRESSIN"], "rxcui": ["2612431", "2612436"], "spl_id": ["1d0832a2-debc-40bf-8bbe-59383d0bd3c6"], "spl_set_id": ["3a35b86c-f451-4fac-8499-43019e4da354"], "package_ndc": ["43825-200-01"], "is_original_packager": [true], "nui": ["N0000194045", "N0000194046"], "pharm_class_epc": ["Vasopressin Receptor Agonist [EPC]"], "pharm_class_moa": ["Vasopressin Receptor Agonists [MoA]"], "unii": ["7Z5X49W53P"]}, "product_type": "Drugs", "event_id": "93945", "recalling_firm": "Mallinckrodt Hospital Products Inc.", "address_1": "440 Us Highway 22", "address_2": "Ste 302", "postal_code": "08807-2477", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0341-2024", "product_description": "Terlivaz (terlipressin for injection), 0.85mg/vial, Single-Dose Vial, Rx only, Distributed by: Mallinckrodt Hospital Products Inc., Bridgewater, NJ 08807, USA, NDC 43825-200-01", "product_quantity": "421 vials involved in this recall (2,448 vials distributed)", "reason_for_recall": "cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.", "recall_initiation_date": "20240206", "center_classification_date": "20240221", "report_date": "20240228", "code_info": "Lot #: 22TRP01-F2, Exp 6/30/2024"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205467"], "brand_name": ["FEBUXOSTAT"], "generic_name": ["FEBUXOSTAT"], "manufacturer_name": ["NorthStar RxLLC"], "product_ndc": ["16714-059", "16714-060"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FEBUXOSTAT"], "rxcui": ["834235", "834241"], "spl_id": ["0284b7a5-7a1f-4e37-9883-b7bdba68c42b"], "spl_set_id": ["ad40e0f6-850c-429a-87fc-f1eb2361e962"], "package_ndc": ["16714-059-01", "16714-060-01"], "is_original_packager": [true], "upc": ["0316714060019"], "nui": ["N0000175698", "N0000000206"], "pharm_class_epc": ["Xanthine Oxidase Inhibitor [EPC]"], "pharm_class_moa": ["Xanthine Oxidase Inhibitors [MoA]"], "unii": ["101V0R1N2E"]}, "product_type": "Drugs", "event_id": "94142", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0368-2024", "product_description": "Febuxostat Tablets 40mg, RX Only, 30 Tablets per bottle, NorthStarx, Manufactured for: Northstar Rx LLC., Memphis, TN 38141 , Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India, NDC 16714-059-01.", "product_quantity": "47,520 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240304", "center_classification_date": "20240308", "report_date": "20240320", "code_info": "Lot #s: DNE0865A, DNE0866A, Exp 06/30/2025"}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0375-2024", "product_description": "TRP Natural Eyes Allergy Eyes Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-032-15.", "product_quantity": "30,240 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: A703, Exp: 02-15-2026, A704, Exp: 03-22-2026, A705, Exp: 04-05-2026"}, {"status": "Completed", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93929", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "The product was distributed nationwide within the United States.", "recall_number": "D-0324-2024", "product_description": "HydrALAZINE Hydrochloride Tablets, USP 10mg, packaged in 100-count (10x10 blister cards), Lot T04680, Rx only, Manufactured for Heritage Pharmaceuticals, Inc. Eatontown, NJ, Distributed by Major Pharmaceuticals Livonia MI. NDC 0904-6440-61", "product_quantity": "8,198 units", "reason_for_recall": "an out of specification result obtained during routine stability testing for Impurities.  There is a remote possibility that use of this product could cause a medically reversible or transient adverse health consequences.", "recall_initiation_date": "20240209", "center_classification_date": "20240213", "report_date": "20240221", "code_info": "Lot #: T04680, Exp. Date 6/2024"}, {"status": "Terminated", "city": "Rosenberg", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93986", "recalling_firm": "Seatex LLC", "address_1": "445 Highway 36 N", "address_2": "", "postal_code": "77471-8756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0356-2024", "product_description": "PROBLEND Antibacterial Foaming Silk All-In-One Foaming Hand Sanitizer & Cleanser, Benzalkonium Chloride 0.13% Antibacterial, a) 1250 mL cases, b) 1 G cases, mountain spring scent, Seatex LLC, 445 TX Hwy 36 Rosenberg, TX 77471.", "product_quantity": "1,450 cases", "reason_for_recall": "CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.", "recall_initiation_date": "20240219", "center_classification_date": "20240229", "termination_date": "20250815", "report_date": "20240306", "code_info": "Lot #s: a) 263647, Exp. 06/09/2024; 271382, Exp. 01/18/2025; b) 261675, Exp. 04/09/2024; 263647, Exp. 06/09/2024; 272766, Exp.02/15/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0239-2024", "product_description": "Old Spice, SWEAT DEFENSE, STRONGER SWAGGER, Dry Spray, 48 Hour, (Aluminum Chlorohydrate 23.5%), Anti-Perspirant, Topical Spray Can, Net WT 3.8 oz (107 g),  Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC 69423-386-10, UPC 0 37000 73034 7 OR UPC 0 12044 04475 9 (12 Pack, older label)", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023,"}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0246-2024", "product_description": "Secret, Dry Spray, Aluminum chlorohydrate 23.5%, Antiperspirant, Rose, Topical spray can Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC:  69423-380-10, UPC 0 37000 79884 2", "product_quantity": "unknown", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "Lot #: 12001458SF, Exp 06/30/2023."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204838"], "brand_name": ["ARIPIPRAZOLE"], "generic_name": ["ARIPIPRAZOLE"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-896", "65162-897", "65162-898", "65162-899", "65162-901", "65162-902"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ARIPIPRAZOLE"], "rxcui": ["349490", "349545", "349547", "349553", "402131", "602964"], "spl_id": ["5542550f-333a-4c31-9430-ffef95401cc5"], "spl_set_id": ["06dda03f-8481-46d6-af02-4f51e1a3a065"], "package_ndc": ["65162-896-03", "65162-896-09", "65162-896-50", "65162-896-11", "65162-897-03", "65162-897-09", "65162-897-50", "65162-897-11", "65162-898-03", "65162-898-09", "65162-898-50", "65162-898-11", "65162-899-03", "65162-899-09", "65162-899-50", "65162-899-11", "65162-901-03", "65162-901-09", "65162-901-50", "65162-901-11", "65162-902-03", "65162-902-09", "65162-902-50", "65162-902-11"], "is_original_packager": [true], "nui": ["N0000175430"], "pharm_class_epc": ["Atypical Antipsychotic [EPC]"], "unii": ["82VFR53I78"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0167-2024", "product_description": "Aripiprazole Tablets, USP, 5 mg, 30 Tablets per bottle, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.  NDC: 65162-897-03", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch AR202318", "more_code_info": ""}, {"status": "Ongoing", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M"], "brand_name": ["BRONCOCHEM"], "generic_name": ["ACETAMINOPHEN-PHENYLEPHRINE HYDROCHLORIDE-CHLORPHENIRAMINE MALEATE"], "manufacturer_name": ["LABORATORIO MAGNACHEM INTERNATIONAL SRL"], "product_ndc": ["65131-097"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN", "CHLORPHENIRAMINE MALEATE"], "spl_id": ["54539b4d-eb99-4198-8486-bfac15605c04"], "spl_set_id": ["b7d3f54e-59ef-4b85-a88d-b053058dc1f6"], "package_ndc": ["65131-097-52", "65131-097-53", "65131-097-12"], "is_original_packager": [true], "upc": ["0805418097532"], "unii": ["362O9ITL9D", "V1Q0O9OJ9Z"]}, "product_type": "Drugs", "event_id": "94015", "recalling_firm": "Global Corporation", "address_1": "621 Nw 53rd St Ste 240", "address_2": "N/A", "postal_code": "33487-8291", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0387-2024", "product_description": "Broncochem Cold & Tea (acetaminophen, phenylephrine, HCl, chlorpheniramine maleate), packaged in 13g sachets, 25 sachets per box, Made in the Dominican Republic Exclusively for Global Corporation Inc, Boca Raton, FL 33187 USA, NDC 65131-097-12", "product_quantity": "2345 boxes", "reason_for_recall": "Stability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or Chlorpheniramine Maleate.", "recall_initiation_date": "20240216", "center_classification_date": "20240314", "report_date": "20240320", "code_info": "Lot #: 123255, 123256, Exp. Date 11/2024; 123637, Exp. Date 03/2025"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065129"], "brand_name": ["CEFIXIME"], "generic_name": ["CEFIXIME"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-405", "68180-407", "68180-416", "68180-423"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFIXIME"], "rxcui": ["309058", "409823", "419849"], "spl_id": ["735f86f4-369c-4f5a-adbe-7dacea2e27b4"], "spl_set_id": ["6d68dbd9-7d75-4ff1-91db-79ff8ae879ec"], "package_ndc": ["68180-405-01", "68180-407-03", "68180-407-04", "68180-416-08", "68180-416-11", "68180-423-11", "68180-423-08"], "is_original_packager": [true], "upc": ["0368180423089", "0368180407034", "0368180416081", "0368180416111"], "unii": ["97I1C92E55"]}, "product_type": "Drugs", "event_id": "93730", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0274-2024", "product_description": "Cefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by:Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01", "product_quantity": "4,608 Bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20240103", "center_classification_date": "20240126", "termination_date": "20241227", "report_date": "20240207", "code_info": "Lot #: F304833, Exp 06/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040362"], "brand_name": ["PREDNISONE"], "generic_name": ["PREDNISONE"], "manufacturer_name": ["Jubilant Cadista Pharmacuticals Inc."], "product_ndc": ["59746-172", "59746-782", "59746-173", "59746-175", "59746-783"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PREDNISONE"], "rxcui": ["198145", "198146", "198148", "312615", "312617"], "spl_id": ["df446a08-be40-429f-8316-05fb59dbea30"], "spl_set_id": ["931ceb82-23b9-46c6-a00b-4cd66ed6f88f"], "package_ndc": ["59746-782-30", "59746-782-01", "59746-172-10", "59746-172-06", "59746-173-10", "59746-173-09", "59746-173-06", "59746-175-09", "59746-175-06", "59746-175-10", "59746-783-01"], "is_original_packager": [true], "upc": ["0359746173067", "0359746172060", "0359746783013", "0359746782306"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["VB0R961HZT"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0193-2024", "product_description": "PredniSONE Tablets, USP, 20 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801.  NDC: 59746-175-06", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 21P0659", "more_code_info": ""}, {"status": "Ongoing", "city": "Portland", "state": "OR", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93941", "recalling_firm": "Today The World", "address_1": "1954 NE Glisan St # 405", "address_2": "N/A", "postal_code": "97220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product distributed nationwide within the United States.", "recall_number": "D-0345-2024", "product_description": "Arize Herbal Dietary Supplement, packaged in 10 capsules per box, Distributed by: Natural Herbal Remedies, LLC, Cheyenne, WY 82001, www.getarize.com", "product_quantity": "5500 boxes", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared nortadalafil, an ingredient found in FDA approved product for the treatment of male sexual enhancement, making this drug an unapproved drug.", "recall_initiation_date": "20240206", "center_classification_date": "20240222", "report_date": "20240228", "code_info": "Lot #: 2107, Exp. Date 10/31/2024."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204161"], "brand_name": ["METOPROLOL SUCCINATE"], "generic_name": ["METOPROLOL SUCCINATE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["45963-676", "45963-709", "45963-677", "45963-678"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METOPROLOL SUCCINATE"], "rxcui": ["866412", "866419", "866427", "866436"], "spl_id": ["47c780a8-9c6a-4de7-8150-be03c28d7404"], "spl_set_id": ["b798601e-a369-4c8b-8235-08900e1b751d"], "package_ndc": ["45963-709-11", "45963-709-96", "45963-676-11", "45963-676-96", "45963-677-11", "45963-677-96", "45963-678-11"], "is_original_packager": [true], "unii": ["TH25PD4CCB"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0191-2024", "product_description": "Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.  NDC: 45963-676-96", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 2447J211", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0256-2024", "product_description": "Secret Dry Spray, Aluminum chlorohydrate 23.5%, Antiperspirant, Rose, Topical spray can Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC:  69423-380-10, UPC 0 37000 79884 2", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0187-2024", "product_description": "Lillow (Levonorgestrel and Ethinyl Estradiol Tablets, USP), 0.15 mg/0.03 mg, 1 Blister Pack Containing 28 Tablets, Rx only,  Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC 69238-1554-6", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch A5921", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA071972"], "brand_name": ["PROPRANOLOL HYDROCHLORIDE"], "generic_name": ["PROPRANOLOL HYDROCHLORIDE"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-2077", "69238-2078", "69238-2079", "69238-2080", "69238-2081"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PROPRANOLOL HYDROCHLORIDE"], "rxcui": ["856448", "856457", "856519", "856556", "856578"], "spl_id": ["542e83a2-c56a-4910-b23c-8d1f4daabfc6"], "spl_set_id": ["14d0c95d-418f-40a8-bad3-e20c82424960"], "package_ndc": ["69238-2077-1", "69238-2077-7", "69238-2078-1", "69238-2078-7", "69238-2079-1", "69238-2079-7", "69238-2080-1", "69238-2081-1", "69238-2081-5"], "is_original_packager": [true], "upc": ["0369238207811", "0369238208016", "0369238207910", "0369238208115"], "unii": ["F8A3652H1V"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0194-2024", "product_description": "Propranolol Hydrochloride Tablets, 20 mg, 100 Tablets per bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.  NDC:  69238-2078-1", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 100023596", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090034"], "brand_name": ["RIFAMPIN"], "generic_name": ["RIFAMPIN"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-658", "68180-659"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIFAMPIN"], "rxcui": ["198201", "198202"], "spl_id": ["3c9f0101-dcf8-487e-985e-09c56746d3a1"], "spl_set_id": ["b56004f0-f23d-47f6-80c7-39884fccbccc"], "package_ndc": ["68180-658-06", "68180-658-01", "68180-659-06", "68180-659-07", "68180-659-01"], "is_original_packager": [true], "nui": ["N0000175500", "M0019113"], "pharm_class_epc": ["Rifamycin Antibacterial [EPC]"], "pharm_class_cs": ["Rifamycins [CS]"], "unii": ["VJT6J7R4TR"]}, "product_type": "Drugs", "event_id": "93753", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution sites.", "recall_number": "D-0284-2024", "product_description": "Rifampin Capsules USP 300mg, 30-count bottle, Rx Only, Manufactured for:  Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured Lupin Limited, Aurangabad 431 210 INDIA, NDC 68180-659-06", "product_quantity": "165,60 bottles", "reason_for_recall": "Subpotent Drug and Failed Impurities/Degradation Specifications", "recall_initiation_date": "20240105", "center_classification_date": "20240130", "termination_date": "20240827", "report_date": "20240207", "code_info": "A200817 exp 1/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Mississauga", "state": "", "country": "Canada", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94066", "recalling_firm": "Contract Pharmaceuticals Limited Canada", "address_1": "7600 East Danbro Cres", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S. and Puerto Rico", "recall_number": "D-0365-2024", "product_description": "Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60", "product_quantity": "11,750 bottles", "reason_for_recall": "Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.", "recall_initiation_date": "20240220", "center_classification_date": "20240301", "report_date": "20240313", "code_info": "Lot #: 119874; Exp 06/30/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE"], "manufacturer_name": ["CVS Pharmacy, Inc."], "product_ndc": ["51316-881"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["2a807f1b-9870-a9ea-e063-6394a90aed25"], "spl_set_id": ["fb808dc5-bf80-836c-e053-6294a90a80aa"], "package_ndc": ["51316-881-10"], "is_original_packager": [true], "upc": ["0050428346495"], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "93682", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide.", "recall_number": "D-0229-2024", "product_description": "CVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE Grape Flavor 10 fl. oz, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, NDC 51316-881-10.", "product_quantity": "13,344 bottles", "reason_for_recall": "MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.", "recall_initiation_date": "20231221", "center_classification_date": "20240112", "report_date": "20240124", "code_info": "Lot A80763; Exp. 11/2025"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA071586"], "brand_name": ["ALLOPURINOL"], "generic_name": ["ALLOPURINOL"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-729", "55111-730"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ALLOPURINOL"], "rxcui": ["197319", "197320"], "spl_id": ["c3be239e-a0b5-fb8d-2ae6-372cef6fa362"], "spl_set_id": ["19a138b8-d225-03e6-f762-abe71560204b"], "package_ndc": ["55111-729-01", "55111-729-10", "55111-730-01", "55111-730-05"], "is_original_packager": [true], "upc": ["0355111729013", "0355111730019"], "nui": ["N0000175698", "N0000000206"], "pharm_class_epc": ["Xanthine Oxidase Inhibitor [EPC]"], "pharm_class_moa": ["Xanthine Oxidase Inhibitors [MoA]"], "unii": ["63CZ7GJN5I"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0164-2024", "product_description": "ALLOPURINOL Tablets, USP 300 MG 500 count Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106.  NDC: 55111-730-05", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch L100813", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0254-2024", "product_description": "Secret, Dry Spray, Aluminum chlorohydrate 23.5% Antiperspirant, Waterlily, Topical Spray Can, Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-381-10; UPC 0 37000 72372 1; 12/pack UPC 0 37000 72991 4", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94071", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0363-2024", "product_description": "Lidocaine HCL 1% (10mg/mL),  PHENYLephrine HCL 1.5% (15mg/mL), 1 ml in a Single- Dose Vial, RX Only, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-090-42", "product_quantity": "40,890 vials", "reason_for_recall": "Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.", "recall_initiation_date": "20240220", "center_classification_date": "20240229", "report_date": "20240306", "code_info": "Lot #:2331104, Exp:9-Mar-24; 2331137, Exp: 3-Mar-24; 2331196, Exp: 11-Mar-24; 2331264, Exp: 6-Apr-24; 2331282, Exp: 18-Apr-24; 2331464, Exp: 8-May-24; 2331481, Exp: 16-May-24; 2331500, Exp: 20-May-24.", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200484"], "brand_name": ["NIACIN"], "generic_name": ["NIACIN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-539", "47335-614", "47335-613"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NIACIN"], "rxcui": ["1098134", "1098141", "1098143"], "spl_id": ["bc18daa3-5321-43bd-9d00-dabd9adac571"], "spl_set_id": ["8e290f96-e8c6-47fd-863f-1c9480f28d9b"], "package_ndc": ["47335-539-83", "47335-539-81", "47335-539-88", "47335-539-08", "47335-539-18", "47335-614-83", "47335-614-81", "47335-614-88", "47335-614-18", "47335-613-83", "47335-613-81", "47335-613-88", "47335-613-08", "47335-613-18"], "is_original_packager": [true], "upc": ["0347335613810", "0347335614817", "0347335539813"], "nui": ["N0000175594", "M0014839"], "pharm_class_epc": ["Nicotinic Acid [EPC]"], "pharm_class_cs": ["Nicotinic Acids [CS]"], "unii": ["2679MF687A"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0270-2024", "product_description": "Niacin Extended-Release Tablets, USP 500mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA, NDC 47335-539-81.", "product_quantity": "15,768 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #s: DNE0771A Exp. 06/30/2025; DNE0857A, DNE0959A Exp. 07/31/2025."}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200484"], "brand_name": ["NIACIN"], "generic_name": ["NIACIN"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-539", "47335-614", "47335-613"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NIACIN"], "rxcui": ["1098134", "1098141", "1098143"], "spl_id": ["bc18daa3-5321-43bd-9d00-dabd9adac571"], "spl_set_id": ["8e290f96-e8c6-47fd-863f-1c9480f28d9b"], "package_ndc": ["47335-539-83", "47335-539-81", "47335-539-88", "47335-539-08", "47335-539-18", "47335-614-83", "47335-614-81", "47335-614-88", "47335-614-18", "47335-613-83", "47335-613-81", "47335-613-88", "47335-613-08", "47335-613-18"], "is_original_packager": [true], "upc": ["0347335613810", "0347335614817", "0347335539813"], "nui": ["N0000175594", "M0014839"], "pharm_class_epc": ["Nicotinic Acid [EPC]"], "pharm_class_cs": ["Nicotinic Acids [CS]"], "unii": ["2679MF687A"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0269-2024", "product_description": "Niacin Extended-Release Tablets, USP 1000mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA, NDC 47335-613-81.", "product_quantity": "6552 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #: DNE0788A Exp. 07/31/2025"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0303-2024", "product_description": "EQUATE brand Hydration PF Lubricant Eye Drops (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%) packaged in 0.34 FL OZ (10 mL) bottles, Distributed by: Walmart Inc., Bentonville, AR 72712, NDC 79903-168-01", "product_quantity": "33,984 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA064076"], "brand_name": ["AMOXICILLIN"], "generic_name": ["AMOXICILLIN"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-2020", "0781-2613", "0781-5060", "0781-5061", "0781-6039", "0781-6156", "0781-6041", "0781-6157"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMOXICILLIN"], "rxcui": ["239191", "308182", "308189", "308191", "308192", "308194", "313797", "313850"], "spl_id": ["6aa02079-d11c-4d2f-acaf-9548dd9a7ed6"], "spl_set_id": ["13bd4214-9b7f-425b-af5f-fc1ddc678230"], "package_ndc": ["0781-2020-31", "0781-2020-76", "0781-2020-01", "0781-2020-05", "0781-2613-31", "0781-2613-76", "0781-2613-01", "0781-2613-05", "0781-5060-20", "0781-5060-01", "0781-5061-20", "0781-5061-01", "0781-6039-58", "0781-6039-46", "0781-6039-55", "0781-6156-52", "0781-6156-57", "0781-6156-46", "0781-6041-58", "0781-6041-46", "0781-6041-55", "0781-6157-52", "0781-6157-57", "0781-6157-46"], "is_original_packager": [true], "upc": ["0307816156526", "0307812020012", "0307816041587", "0307815060015", "0307815061012", "0307816157523", "0307816039584", "0307812613016"], "unii": ["804826J2HU"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0166-2024", "product_description": "AMOXICILLIN Tablets, USP, 875MG, 20 Tablets, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540.  NDC: 0781-5060-20", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch LJ9004", "more_code_info": ""}, {"status": "Ongoing", "city": "Massena", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION INC"], "product_ndc": ["63868-608"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "spl_id": ["fe2fd512-7a50-4341-a82e-30fdc9eea7c9"], "spl_set_id": ["aebc7cf8-aaf7-4746-89f5-a64d0be1641e"], "package_ndc": ["63868-608-01"], "is_original_packager": [true], "unii": ["K89MJ0S5VY"], "upc": ["635515988460"]}, "product_type": "Drugs", "event_id": "93708", "recalling_firm": "Seaway Pharma Inc.", "address_1": "5 County Route 42", "address_2": "N/A", "postal_code": "13662-1569", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MI, PA", "recall_number": "D-0217-2024", "product_description": "Quality Choice No Drip Severe Congestion Nasal Pump Mist, Oxymetazoline hydrochloride 0.05%, Nasal Decongestant, 12 Hours, 1 fl. oz. bottle, Distributed by C.D.M.A., Inc., 43157 W 9 Mile Rd., Novi, MI 48375, NDC 63868-608-01, UPC 6-35515-98846-0", "product_quantity": "8,160 bottles", "reason_for_recall": "CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.", "recall_initiation_date": "20231228", "center_classification_date": "20240104", "report_date": "20240110", "code_info": "Lot # SE23035, Exp 05/31/2026"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0298-2024", "product_description": "CVS Health brand, Lubricant Gel Drops (Carboxymethylcellulose Sodium 1%) packaged in a) 0.5 FL OZ (15mL) bottles (Single Pack) (NDC 76168-704-15) and b) 0.5 FL OZ (15 mL) bottles (Twin pack) (NDC 76168-704-30), Distributed by: CVS Pharmacy Inc. One CVS Drive Woonsocket, RI 02895.", "product_quantity": "150,720 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Massena", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93708", "recalling_firm": "Seaway Pharma Inc.", "address_1": "5 County Route 42", "address_2": "N/A", "postal_code": "13662-1569", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MI, PA", "recall_number": "D-0215-2024", "product_description": "Premier Value Tussin Cough DM, Dextromethorphan HBr...Cough Suppressant, Guaifenesin...Expectorant, Alcohol Free, 8 FL OZ (237 mL) bottle, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne PA 19087, UPC 8-40986-03789-4.", "product_quantity": "4,176 bottles", "reason_for_recall": "CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.", "recall_initiation_date": "20231228", "center_classification_date": "20240104", "report_date": "20240110", "code_info": "Lot # SD23033, Exp 04/30/2025"}, {"status": "Ongoing", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fafec0-59d7-1a67-e063-6294a90a8f1e"], "spl_set_id": ["bbc5b820-4973-11e2-a192-0002a5d5c51b"], "package_ndc": ["49230-206-20", "49230-206-30", "49230-206-32", "49230-206-50", "49230-206-60", "49230-206-62", "49230-206-52", "49230-209-23", "49230-209-30", "49230-209-32", "49230-209-50", "49230-209-60", "49230-209-62", "49230-209-52", "49230-212-23", "49230-212-30", "49230-212-32", "49230-212-50", "49230-212-60", "49230-212-62", "49230-212-52"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "93690", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 920", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0218-2024", "product_description": "DELFLEX Peritoneal Dialysis Solution in Biofine container 1.5% Dextrose, packaged in 6000mL bags, Rx only, Fresenius Medical Care NA Waltham, MA 02451, NDC 49230-206-62.", "product_quantity": "69,590 bags", "reason_for_recall": "Lack of Sterility Assurance", "recall_initiation_date": "20231228", "center_classification_date": "20240104", "report_date": "20240110", "code_info": "Part Number: 077-60621, Lot #: 23JK02010, Exp. Date 1/31/2025"}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY"], "manufacturer_name": ["Pharma Nobis, LLC"], "product_ndc": ["82645-312"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["0d1c551e-97f4-67fe-e063-6394a90a2b10"], "spl_set_id": ["f0489f6f-9e60-7d69-e053-2a95a90a9dfb"], "package_ndc": ["82645-312-10"], "is_original_packager": [true], "upc": ["0382645312107"], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "93682", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide.", "recall_number": "D-0231-2024", "product_description": "Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Cherry Flavor 10 fl. oz, Manufactured by: Pharma Lobis, 7400 Alumax Dr., Texarkana, TX 75501, NDC 82645-312-10.", "product_quantity": "7,404 Bottles", "reason_for_recall": "MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.", "recall_initiation_date": "20231221", "center_classification_date": "20240112", "report_date": "20240124", "code_info": "Lot A80622; Exp. 11/2025"}, {"status": "Ongoing", "city": "Kansas City", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93808", "recalling_firm": "Neptune Resources, LLC", "address_1": "1324 W 12th St Fl 5", "address_2": "N/A", "postal_code": "64101-1343", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0335-2024", "product_description": "Neptune's Fix, Tianeptine Tablets Extended Relief, Twenty Tablets per Box, Wide Awake, 3000 mg (150 mg Per Tablet), Distributed By Neptune Resources, LLC, 30 N. Gould Street, Ste R, Sheridan, WY 82801.", "product_quantity": "4,932 boxes", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.", "recall_initiation_date": "20240112", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "All lots"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {"application_number": ["M018"], "brand_name": ["LUBRICANT DROPS"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "manufacturer_name": ["CARDINAL HEALTH 110, LLC. DBA LEADER"], "product_ndc": ["70000-0090"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED"], "rxcui": ["1188426"], "spl_id": ["7032f298-3bfe-4fd2-b240-36ec6015ffbe"], "spl_set_id": ["1ac2fe24-9ff6-48c1-b123-fbc0e48f5304"], "package_ndc": ["70000-0090-1", "70000-0090-2"], "is_original_packager": [true], "unii": ["K679OBS311"]}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0291-2024", "product_description": "Leader brand Lubricant Eye Drops (Carboxymethylcellulose Sodium 0.5%), packaged in a) 0.5 FL OZ (15mL) bottles (Single Pack)  (NDC 70000-0090-1) and b) 0.5 FL OZ (15 mL) bottles (Twin pack) (NDC 70000-0090-2), Distributed by: Cardinal Health Dublin, Ohio 43017", "product_quantity": "210,192 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205467"], "brand_name": ["FEBUXOSTAT"], "generic_name": ["FEBUXOSTAT"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-721", "47335-722"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FEBUXOSTAT"], "rxcui": ["834235", "834241"], "spl_id": ["53dfe063-e9bf-4069-b4cc-5a83a27d18ec"], "spl_set_id": ["1f7541bd-bf32-422b-b99a-89193cf193ca"], "package_ndc": ["47335-721-83", "47335-721-81", "47335-721-13", "47335-722-83", "47335-722-88", "47335-722-18"], "is_original_packager": [true], "nui": ["N0000175698", "N0000000206"], "pharm_class_epc": ["Xanthine Oxidase Inhibitor [EPC]"], "pharm_class_moa": ["Xanthine Oxidase Inhibitors [MoA]"], "unii": ["101V0R1N2E"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0265-2024", "product_description": "Febuxostat Tablets 80 mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA, NDC 47335-722-83.", "product_quantity": "19,992 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #s: DNE0867A Exp. 06/30/2025, DNE0894B Exp. 07/31/2025"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {"application_number": ["M018"], "brand_name": ["DRY EYE RELIEF"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM"], "manufacturer_name": ["CARDINAL HEALTH 110, LLC. DBA LEADER"], "product_ndc": ["70000-0089"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED"], "rxcui": ["579907"], "spl_id": ["b2fd3f1c-69bb-4c0c-9a11-1c135377045c"], "spl_set_id": ["bd262028-32e9-052d-e053-2a95a90a5303"], "package_ndc": ["70000-0089-1"], "is_original_packager": [true], "unii": ["K679OBS311"]}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0299-2024", "product_description": "Leader brand Dry Eye Relief (Carboxymethylcellulose Sodium 1%), packaged in 0.5 FL OZ (15 mL) bottles, Cardinal Health Dublin, Ohio 43017, NDC 70000-0089-1", "product_quantity": "23,208 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA202494"], "brand_name": ["SODIUM BICARBONATE"], "generic_name": ["SODIUM BICARBONATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-6637", "0409-4916"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM BICARBONATE"], "rxcui": ["727995", "792582"], "spl_id": ["f79ec8cb-b6a3-4ffb-bccf-d39f59d65621"], "spl_set_id": ["ea20a5eb-641e-48cd-bcfa-74c04c45dfda"], "package_ndc": ["0409-4916-24", "0409-4916-14", "0409-6637-24", "0409-6637-14"], "is_original_packager": [true], "unii": ["8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "93681", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0234-2024", "product_description": "8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 50 mL Syringe per Carton, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6637-24 (carton), 0409-6637-14 (case).", "product_quantity": "21200 Cartons", "reason_for_recall": "Presence of Particulate Matter; identified as glass", "recall_initiation_date": "20231221", "center_classification_date": "20240117", "report_date": "20240124", "code_info": "Lot HA7295, EXP 03/01/2025"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202687"], "brand_name": ["METHOXSALEN"], "generic_name": ["METHOXSALEN"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-752"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METHOXSALEN"], "rxcui": ["1812434"], "spl_id": ["2af91a53-9d36-4415-b4f3-cd78b8ad36ad"], "spl_set_id": ["a6ec8292-9189-4ebd-862a-e1725eb29eef"], "package_ndc": ["64380-752-16"], "is_original_packager": [true], "nui": ["N0000010217", "N0000175984", "N0000009801", "N0000175879", "M0017973"], "pharm_class_moa": ["Photoabsorption [MoA]"], "pharm_class_epc": ["Photoactivated Radical Generator [EPC]", "Psoralen [EPC]"], "pharm_class_pe": ["Photosensitizing Activity [PE]"], "pharm_class_cs": ["Psoralens [CS]"], "unii": ["U4VJ29L7BQ"]}, "product_type": "Drugs", "event_id": "93703", "recalling_firm": "Strides Pharma Inc.", "address_1": "2 Tower Center Blvd Ste 1102", "address_2": "N/A", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0260-2024", "product_description": "Methoxsalen Capsules, USP 10mg, 50-count bottle, Rx Only, Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India. Distributed by:Strides Pharma Inc. East Brunswick, NJ 08816, NDC 64380-752-16", "product_quantity": "396 50-count bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20231229", "center_classification_date": "20240124", "termination_date": "20250701", "report_date": "20240131", "code_info": "Lot #: 7253092B, Exp Date 09/30/2025"}, {"status": "Ongoing", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93702", "recalling_firm": "Haleon US Holdings LLC", "address_1": "184 Liberty Corner Rd", "address_2": "N/A", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0316-2024", "product_description": "Robitussin Honey CF Max Non-Drowsy Adult (Acetaminophen 650mg, Dextromethorphan HBr 20 mg), a) 4 FL OZ (118mL) and b) 8 FL OZ (237 mL) bottles, Distributed by: GSK Consumer Healthcare, Warren, NJ 07059", "product_quantity": "a) 31,632 bottles; b) 336,528 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20231226", "center_classification_date": "20240207", "report_date": "20240131", "code_info": "a) Lot#: T10810, Exp 10/31/2025 b) Lot#: T08730, T08731, T08732, T08733, Exp 05/31/2025; T10808, Exp 09/30/2025"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078352"], "brand_name": ["DESLORATADINE"], "generic_name": ["DESLORATADINE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-153"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DESLORATADINE"], "rxcui": ["349420"], "spl_id": ["511ec9ae-ec30-43cd-b408-4febb49716ac"], "spl_set_id": ["2a90b899-7746-43dc-ac8a-e754428eb30c"], "package_ndc": ["68180-153-01", "68180-153-03", "68180-153-06", "68180-153-02", "68180-153-11", "68180-153-12"], "is_original_packager": [true], "upc": ["0368180153016", "0368180153023"], "nui": ["N0000000190", "N0000175587"], "pharm_class_moa": ["Histamine H1 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Histamine-1 Receptor Antagonist [EPC]"], "unii": ["FVF865388R"]}, "product_type": "Drugs", "event_id": "93669", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0221-2024", "product_description": "Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202.", "product_quantity": "100=29,184 bottles; 500=2922 bottles", "reason_for_recall": "CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.", "recall_initiation_date": "20231220", "center_classification_date": "20240109", "termination_date": "20250404", "report_date": "20240117", "code_info": "Lot #  G201822, exp. date Jan 2024, 100 count G201823, exp. date Jan 2024, 100 count G201824, exp. date Jan 2024, 500 count", "more_code_info": ""}, {"status": "Completed", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M017"], "brand_name": ["AMERICAINE"], "generic_name": ["BENZOCAINE"], "manufacturer_name": ["Insight Pharmaceuticals LLC"], "product_ndc": ["63736-378"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["BENZOCAINE"], "rxcui": ["211315", "360349"], "spl_id": ["d727db6e-b2c9-4bf6-96c5-751713baaf6a"], "spl_set_id": ["4fd14452-0285-40c4-b835-36935c2056b2"], "package_ndc": ["63736-378-02"], "is_original_packager": [true], "nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_cs": ["Allergens [CS]"], "unii": ["U3RSY48JW5"], "upc": ["363736378820"]}, "product_type": "Drugs", "event_id": "93691", "recalling_firm": "Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company", "address_1": "660 White Plains Rd Ste 250", "address_2": "N/A", "postal_code": "10591-5171", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0236-2024", "product_description": "Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight Pharmaceuticals Corp. Tarrytown, NY 10591, USA, A Prestige Consumer Healthcare company. Made in India. NDC 63736-378-02, Can UPC 3 63736 37882 0; Case UPC 1 03 63736 37882 7", "product_quantity": "34,704 cans", "reason_for_recall": "Chemical Contamination: presence of benzene", "recall_initiation_date": "20231221", "center_classification_date": "20240117", "report_date": "20240124", "code_info": "Lot # 1A16420, exp. date 01/31/2025"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065056"], "brand_name": ["AMOXICILLIN"], "generic_name": ["AMOXICILLIN"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-2263", "0093-2264", "0093-4160", "0093-4155", "0093-4161", "0093-2267", "0093-2268", "0093-3107", "0093-3109"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMOXICILLIN"], "rxcui": ["239191", "308177", "308182", "308189", "308191", "308192", "308194", "313850", "598025"], "spl_id": ["31223839-1653-4906-826a-f9d6af179334"], "spl_set_id": ["4c0f348a-a65d-409c-8668-207c82a5e3cb"], "package_ndc": ["0093-2263-01", "0093-2264-01", "0093-4160-76", "0093-4160-78", "0093-4160-73", "0093-4155-79", "0093-4155-73", "0093-4155-80", "0093-4161-76", "0093-4161-78", "0093-4161-73", "0093-2267-01", "0093-2268-01", "0093-3107-01", "0093-3107-05", "0093-3109-53", "0093-3109-05"], "is_original_packager": [true], "upc": ["0300933107051", "0300932264014", "0300934161731", "0300933109055", "0300932267015", "0300932268012", "0300932263017", "0300934160734", "0300934155730"], "unii": ["804826J2HU"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0165-2024", "product_description": "AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVA CANA LIMITED, Toronto, Canada M1B 2K9; Manufactured For: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454.  NDC: 0093-4161-73", "product_quantity": "3 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 35447184A", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0250-2024", "product_description": "Old Spice, PURE SPORT, (Aluminum Chlorohydrate 23.5%), Anti-Perspirant & Deodorant Spray, Topical spray can, Net WT 6.0 OZ (170g), Distributed by Procter & Gamble, Cincinnati, OH 45202.  NDC: 37000-199-60, UPC 0 12044 00191 2", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Ongoing", "city": "Thane", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93885", "recalling_firm": "Brassica Pharma Pvt Ltd", "address_1": "Plot No. T-68, T 68 (Pt), T-63, Midc", "address_2": "Tarapur, Boisar", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0353-2024", "product_description": "CVS Health Lubricant Eye Ointment (Mineral oil 31.9%  Emollient, White petrolatum 57.7% Emollient), Packaged in in 3.5 gram tubes, Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895, NDC 76168-707-35, UPC 050428634141", "product_quantity": "159,334 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240130", "center_classification_date": "20240228", "report_date": "20240306", "code_info": "Lot #:  A2F03, Exp. Date May-24;  A2I02, Exp. Date Aug-24; A2L02, Exp. Date Nov-24; A3C04, Exp. Date Feb-25; A3H04, Exp. Date Jul-25", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077091"], "brand_name": ["GLIMEPIRIDE"], "generic_name": ["GLIMEPIRIDE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-320", "55111-321", "55111-322"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GLIMEPIRIDE"], "rxcui": ["199245", "199246", "199247"], "spl_id": ["e3d50334-9896-b2f9-a481-8383eb84b16a"], "spl_set_id": ["07ad4366-4b21-f633-49f3-c2b35f88168d"], "package_ndc": ["55111-320-30", "55111-320-01", "55111-320-05", "55111-320-79", "55111-320-78", "55111-321-30", "55111-321-01", "55111-321-05", "55111-321-79", "55111-321-78", "55111-322-30", "55111-322-01", "55111-322-05", "55111-322-79", "55111-322-78"], "is_original_packager": [true], "nui": ["N0000175608", "M0020795"], "pharm_class_epc": ["Sulfonylurea [EPC]"], "pharm_class_cs": ["Sulfonylurea Compounds [CS]"], "unii": ["6KY687524K"]}, "product_type": "Drugs", "event_id": "93833", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0312-2024", "product_description": "Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-01", "product_quantity": "59,336 bottles", "reason_for_recall": "Misprint on tablet", "recall_initiation_date": "20240118", "center_classification_date": "20240206", "report_date": "20240214", "code_info": "Lot: T2303622; Exp. 06/2026 Lot: T2303626; Exp. 06/2026 Lot: T2303627; Exp. 06/2026 Lot: T2303628; Exp. 06/2026 Lot: T2303629; Exp. 06/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Wilmington", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA214679"], "brand_name": ["EPRONTIA"], "generic_name": ["TOPIRAMATE"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc."], "product_ndc": ["52652-9001"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TOPIRAMATE"], "rxcui": ["2586427", "2586433"], "spl_id": ["30dc8c36-63cc-07b4-e063-6294a90a9abb"], "spl_set_id": ["e2a4df59-fead-4a01-9021-9eda02c48010"], "package_ndc": ["52652-9001-1", "52652-9001-2", "52652-9001-3"], "is_original_packager": [true], "nui": ["N0000008486", "N0000185506", "N0000182140"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "unii": ["0H73WJJ391"]}, "product_type": "Drugs", "event_id": "93552", "recalling_firm": "Azurity Pharmaceuticals, Inc.", "address_1": "841 Woburn St", "address_2": "N/A", "postal_code": "01887-3414", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0213-2024", "product_description": "Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1", "product_quantity": "2,220 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.", "recall_initiation_date": "20231208", "center_classification_date": "20240102", "termination_date": "20240424", "report_date": "20240110", "code_info": "Lot #: MB22020B, Exp 12/27/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M022"], "brand_name": ["NATURAL CHERRY HONEY HERB THROAT DROPS"], "generic_name": ["MENTHOL"], "manufacturer_name": ["Ricola Ag"], "product_ndc": ["54305-507"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MENTHOL"], "rxcui": ["1429019"], "spl_id": ["894d6e1c-e1f8-4967-8f83-e9d9b1e379cb"], "spl_set_id": ["229a7feb-c646-4557-85e5-0832682ab926"], "package_ndc": ["54305-507-10", "2000058693"], "is_original_packager": [true], "upc": ["0036602074507"], "unii": ["L7T10EIP3A"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0195-2024", "product_description": "Ricola CherryHoney Herb Throat Drops (menthol, 1.8 mg), 10 Drops per roll, Manufacturer: Ricola Ltd., 4242 Laufen, Switzerland; Distributed by: Ricola USA Inc., 6 Campus Drive, 2nd Floor South, Parsippany, NJ 07054.  NDC: 54305-507-10", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 2000058693", "more_code_info": ""}, {"status": "Ongoing", "city": "Verna", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA211711"], "brand_name": ["CLOBAZAM"], "generic_name": ["CLOBAZAM"], "manufacturer_name": ["Micro Labs Limited"], "product_ndc": ["42571-315", "42571-316"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLOBAZAM"], "rxcui": ["199450", "246172"], "spl_id": ["3afc2af9-3600-3648-e063-6394a90a7e51"], "spl_set_id": ["721dde68-db83-4dad-8649-8046cb455372"], "package_ndc": ["42571-315-30", "42571-315-90", "42571-315-05", "42571-315-32", "42571-315-11", "42571-315-20", "42571-315-91", "42571-315-01", "42571-316-30", "42571-316-90", "42571-316-32", "42571-316-11", "42571-316-20", "42571-316-91", "42571-316-01"], "is_original_packager": [true], "upc": ["0342571315016", "0342571316013"], "nui": ["N0000175694", "M0002356", "N0000182137", "N0000185506"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_moa": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "unii": ["2MRO291B4U"]}, "product_type": "Drugs", "event_id": "93975", "recalling_firm": "Micro Labs Limited", "address_1": "Plot# S - 155", "address_2": "& N1 Phase Iii & Phase Iv; Verna Ind Estate Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0348-2024", "product_description": "Clobazam Tablets 10mg, 100-count bottle, Rx Only, Manufactured by: Micro Labs Limited Goa-403 722, India. Manufactured for: Micro Labs USA, Inc. Somerset, NJ 08873. NDC 42571-315-01", "product_quantity": "24,768 bottles", "reason_for_recall": "CGMP Deviations: Out of specification for residual solvents.", "recall_initiation_date": "20240212", "center_classification_date": "20240222", "report_date": "20240228", "code_info": "ZOAG043"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0293-2024", "product_description": "Rugby brand Polyvinyl Alcohol 1.4% Lubricating Eye Drops, packaged in 0.5 FL OZ (15 mL) bottles, Distributed by: Rugby Laboratories, Livonia, MI 48152, NDC 0536-1325-94", "product_quantity": "1,492,344 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0241-2024", "product_description": "Old Spice, SWEAT DEFENSE  ULTIMATE CAPTAIN, Aluminum Chlorohydrate 23.5%, Anti-Perspirant, Topical spray can 3.8 OZ (107 g), Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-385-10, UPC 0 37000 74947 9", "product_quantity": "unknown", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "Lot #: 03581458SA, Exp 11/30/2022;  10251458SU,   10261458SA, Exp 12/31/2022;"}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA021146"], "brand_name": ["ATROPINE SULFATE"], "generic_name": ["ATROPINE SULFATE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1630", "0409-9630", "0409-4910", "0409-4911"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ATROPINE SULFATE"], "rxcui": ["1190546", "1190551", "1190552"], "spl_id": ["ab573c15-9504-48d1-bf4a-d8b8d7ae748a"], "spl_set_id": ["ad8916e7-206e-409e-2582-30d072845dd4"], "package_ndc": ["0409-1630-15", "0409-1630-10", "0409-9630-15", "0409-9630-05", "0409-4910-11", "0409-4910-34", "0409-4911-11", "0409-4911-34"], "is_original_packager": [true], "unii": ["03J5ZE7KA5"]}, "product_type": "Drugs", "event_id": "93681", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0235-2024", "product_description": "Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake FOrest, IL 60045, NDC 0409-4911-11 (carton), 0409-4911-34 (case).", "product_quantity": "24400 Cartons", "reason_for_recall": "Presence of Particulate Matter; identified as glass", "recall_initiation_date": "20231221", "center_classification_date": "20240117", "report_date": "20240124", "code_info": "Lot GY2496, Exp 02/01/2025"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93935", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to three direct accounts in NM, AZ and UT.", "recall_number": "D-0372-2024", "product_description": "Infuvite Adult Multiple vitamins injection, single-dose vial 5mL, Rx only, MFG: Baxter Healthcare Corp., NDC 54643-5649-01", "product_quantity": "70 vials", "reason_for_recall": "cGMP Deviations: Products were stored outside the drug label specifications.", "recall_initiation_date": "20240207", "center_classification_date": "20240308", "termination_date": "20240814", "report_date": "20240320", "code_info": "519644"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94071", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0361-2024", "product_description": "Moxifloxacin PF, 1mg/ml, in Sterile Balanced Salt Solution (BSS) Sterile injection, Intracameral Use Only, Single- Dose Vial, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-096-42", "product_quantity": "40,090 vials", "reason_for_recall": "Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.", "recall_initiation_date": "20240220", "center_classification_date": "20240229", "report_date": "20240306", "code_info": "Lot #:2331147, Exp:6-Mar-24; 2331180, Exp: 21-Mar-24; 2331256, Exp: 2-Apr-24; 2331279, Exp: 3-Apr-24; 2331283, Exp: 7-Apr-24; 2331345, Exp: 20-Apr-24; 2331422, Exp: 27-Apr-24; 2331563, Exp: 29-May-24.", "more_code_info": ""}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93813", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0319-2024", "product_description": "Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd, Oral Solid Dosage Unit, Ahmedabad 382213, India, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 60219-1502-01", "product_quantity": "858 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.", "recall_initiation_date": "20240115", "center_classification_date": "20240208", "termination_date": "20250131", "report_date": "20240214", "code_info": "Lot # AM221153, Exp. date 06/30/2024; AM230497, Exp. date 02/29/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Kansas City", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93808", "recalling_firm": "Neptune Resources, LLC", "address_1": "1324 W 12th St Fl 5", "address_2": "N/A", "postal_code": "64101-1343", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0334-2024", "product_description": "Neptune's Fix, Tianeptine Extra Strength Elixir, 0.338 fl oz (10 mL) bottle, Distributed By Neptune Resources, LLC, 30 N. Gould Street, Ste R, Sheridan, WY 82801.", "product_quantity": "117,000 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.", "recall_initiation_date": "20240112", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "All lots"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0307-2024", "product_description": "Lubricant Gel Drops (Polyethylene glycol 400 0.4%, Propylene glycol 0.3%), packaged in 0.33 FL OZ (10 mL) bottles, Distributed by: Rite Aid 30 Hunter Lane, Camp Hill, PA 17011, NDC 11822-4540-3", "product_quantity": "7,776 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Lompoc", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93831", "recalling_firm": "Den-Mat Holdings, LLC", "address_1": "1017 W Central Ave", "address_2": "", "postal_code": "93436-2701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0286-2024", "product_description": "OralProCare medicated lip treatment, Net Wt 9.9 g (0.35 oz) tube, Ethyl alcohol 6.0% Antibacterial, Manufactured by: Den-Mat Holdings, LLC, Lompoc, CA, 93436, USA, NDC 59883-500-01, UPC: 3 59883 00000 4.", "product_quantity": "344 tubes", "reason_for_recall": "CGMP Deviations: products may not conform to the labeled specifications.", "recall_initiation_date": "20240116", "center_classification_date": "20240131", "report_date": "20240207", "code_info": "Lot #s: 2319500023, Exp: 01- 12-2024; 2330400002, Exp: 11-02-2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090509"], "brand_name": ["TACROLIMUS"], "generic_name": ["TACROLIMUS"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-525", "55111-526", "55111-527"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "rxcui": ["198377", "198378", "313190"], "spl_id": ["706bafff-d629-291c-5ce5-83d74a638860"], "spl_set_id": ["61dee012-43af-0e9a-3843-9b9b91e022c4"], "package_ndc": ["55111-525-30", "55111-525-01", "55111-525-05", "55111-525-79", "55111-525-78", "55111-526-30", "55111-526-01", "55111-526-05", "55111-526-79", "55111-526-78", "55111-527-30", "55111-527-01", "55111-527-05", "55111-527-79", "55111-527-78"], "is_original_packager": [true], "upc": ["0355111527015", "0355111525011", "0355111526018"], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "93622", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0219-2024", "product_description": "Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01", "product_quantity": "8,280 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.", "recall_initiation_date": "20231215", "center_classification_date": "20240105", "termination_date": "20240916", "report_date": "20240117", "code_info": "Lot# C2307275; Exp.  January 2026", "more_code_info": ""}, {"status": "Terminated", "city": "Sarasota", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93847", "recalling_firm": "OMEZA LLC", "address_1": "1610 Northgate Blvd", "address_2": "", "postal_code": "34234-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "US Nationwide", "recall_number": "D-0288-2024", "product_description": "Omeza Lidocaine Lavage pain relief oil 10*2mL VIALS", "product_quantity": "4390 vials", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240119", "center_classification_date": "20240204", "termination_date": "20241017", "report_date": "20240214", "code_info": "Lots:  28622 2-1, Exp. 04/24/2024 286222-3, Exp. 1/25/2024 or 04/25/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Thane", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93885", "recalling_firm": "Brassica Pharma Pvt Ltd", "address_1": "Plot No. T-68, T 68 (Pt), T-63, Midc", "address_2": "Tarapur, Boisar", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0354-2024", "product_description": "Lubricant PM Ointment (Mineral Oil 42.5% and White Petrolatum 57.3%), Packaged in 3.5 gram tubes, Distributed by: AACE Pharmaceuticals, Inc., Fairfield, NJ 07004, NDC 71406-124-35, UPC 371406124356", "product_quantity": "355,120 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240130", "center_classification_date": "20240228", "report_date": "20240306", "code_info": "Lot #: A2G01, A2G02, Exp. Date Jun-24; A3F08, A3F09, Exp. Date May-25; A3J17, A3J18, Exp. Date Sep-25", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202496"], "brand_name": ["IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE"], "generic_name": ["IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-840"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["ALBUTEROL SULFATE", "IPRATROPIUM BROMIDE"], "rxcui": ["1437702"], "spl_id": ["14b7dfcc-b3a8-4027-9544-8d52ec2aacf3"], "spl_set_id": ["89d59bd9-c826-413c-8ed9-a1521a0c7cc5"], "package_ndc": ["69097-840-34", "69097-840-53", "69097-840-87", "69097-840-64"], "is_original_packager": [true], "unii": ["021SEF3731", "J697UZ2A9J"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0161-2024", "product_description": "Ipratropium Bromide and Albuterol Sulfate Inhalation Solution (0.5 mg/3 mg per 3 mL), 60 x 3 mL Sterile Unit-Dose Vials (2 pouches of 30 - 3 mL vials each), Manufactured By: The Ritedose Corporation, Columbia, SC 29203; Distributed By: Cipla USA Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-840-64", "product_quantity": "2 cartons", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 21C56", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0240-2024", "product_description": "Old Spice, SWEAT DEFENSE PURE SPORT PLUS, Dry Spray,  (Aluminum Chlorohydrate 23.5%), Anti-Perspirant, Topical spray can, Net WT 3.8 oz (107 g) cans,  Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-387-10, UPC 0 37000 72974 7", "product_quantity": "unknown", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "Lot #: 12081458SB, Exp 6/30/2021; 92181458FA, Exp 7/31/21;"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA085082"], "brand_name": ["DICYCLOMINE HYDROCHLORIDE"], "generic_name": ["DICYCLOMINE HYDROCHLORIDE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-0794", "0591-0795"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DICYCLOMINE HYDROCHLORIDE"], "rxcui": ["991061", "991086"], "spl_id": ["cdc9e5f4-36d9-40dc-894f-2d8682e4a61b"], "spl_set_id": ["a5937c7b-cdfc-46e6-a0fa-541b24f91d47"], "package_ndc": ["0591-0794-01", "0591-0794-10", "0591-0795-01", "0591-0795-10"], "is_original_packager": [true], "upc": ["0305910795016", "0305910794019"], "unii": ["CQ903KQA31"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0175-2024", "product_description": "Dicyclomine Hydrochloride Tablets, USP 20 mg, 100 Tablets, Rx only, Manufactured For: Teva Pharmaceuticals USA, Parsippany, NJ 07054.  NDC: 0591-0795-01", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 3197790", "more_code_info": ""}, {"status": "Terminated", "city": "Pittsburgh", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93880", "recalling_firm": "Alpha Aromatics", "address_1": "294 Alpha Dr", "address_2": "N/A", "postal_code": "15238-2906", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two accounts in NC and MI", "recall_number": "D-0338-2024", "product_description": "Pure Care Foaming Mint Hand Sanitizer 62%, Distributed by: Air Scent International, 290 Alpha Drive, RIDC Industrial Park, Pittsburg, PA 15238 USA, www.airscent.com, NDC 75009-562.", "product_quantity": "676 gallons", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240125", "center_classification_date": "20240216", "termination_date": "20240814", "report_date": "20240228", "code_info": "Lot # 2022-012884 Lot # 2023-002020 Lot # 2023-003532 Lot # 2023-003761"}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205467"], "brand_name": ["FEBUXOSTAT"], "generic_name": ["FEBUXOSTAT"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-721", "47335-722"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FEBUXOSTAT"], "rxcui": ["834235", "834241"], "spl_id": ["53dfe063-e9bf-4069-b4cc-5a83a27d18ec"], "spl_set_id": ["1f7541bd-bf32-422b-b99a-89193cf193ca"], "package_ndc": ["47335-721-83", "47335-721-81", "47335-721-13", "47335-722-83", "47335-722-88", "47335-722-18"], "is_original_packager": [true], "nui": ["N0000175698", "N0000000206"], "pharm_class_epc": ["Xanthine Oxidase Inhibitor [EPC]"], "pharm_class_moa": ["Xanthine Oxidase Inhibitors [MoA]"], "unii": ["101V0R1N2E"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0264-2024", "product_description": "Febuxostat Tablets 40mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), INDIA, NDC 47335-721-83.", "product_quantity": "55,272 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #s: DNE0866B Exp. 06/30/2025, DNE1045A, DNE1046B Exp. 08/31/2025"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077929"], "brand_name": ["MELOXICAM"], "generic_name": ["MELOXICAM"], "manufacturer_name": ["Cipla USA Inc."], "product_ndc": ["69097-158", "69097-159"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MELOXICAM"], "rxcui": ["152695", "311486"], "spl_id": ["2c9a4c52-7394-432a-9e50-b51c8a90972e"], "spl_set_id": ["bb83cd61-0a82-4fe0-b72e-5b715cbd656d"], "package_ndc": ["69097-158-15", "69097-158-07", "69097-158-12", "69097-159-12", "69097-159-07", "69097-159-15"], "is_original_packager": [true], "upc": ["0369097159078", "0369097158071"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["VG2QF83CGL"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0190-2024", "product_description": "Meloxicam Tablets, USP, 15 mg, 1000 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., Kurkumbh, India; Manufactured for: Cipla USA, Inc., 9100 S. Dadeland Blvd., Suite 1500 Miami, FL 33156.  NDC: 69097-159-15", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch KA11489", "more_code_info": ""}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0381-2024", "product_description": "TRP Natural Eyes Aging Eye Relief, Sterile Eye Drops, Homeopathic, 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-027-15.", "product_quantity": "19,344 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: G806, Exp: 06-01-2025, G807, Exp: 10-27-2026."}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0379-2024", "product_description": "TRP Eye strain Relief, Sterile Eye Drops, Homeopathic, 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-172-15.", "product_quantity": "10,536 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: E206, Exp: 09-21-2025"}, {"status": "Completed", "city": "Mooresville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93869", "recalling_firm": "Bestco LLC", "address_1": "288 Mazeppa Rd", "address_2": "N/A", "postal_code": "28115-7928", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0331-2024", "product_description": "Family Wellness Cherry Cough Drops Menthol cough suppressant/Oral Anesthetic, 80 drops per bag, item number 20001187, Bestco, 288 Mazeppa Road, Mooresville, NC 28115", "product_quantity": "46 cases/6 pack each", "reason_for_recall": "CGMP Deviations: Potential Glass and Silicone particulates in product", "recall_initiation_date": "20240119", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "100042290, Exp 12/31/2026"}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0243-2024", "product_description": "Secret, Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Waterlily, Topical Spray Can, Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-381-10; UPC 0 37000 72372 1; 12/pack UPC 0 37000 72991 4", "product_quantity": "unknown", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "Lot #: 92191458FB, Exp 7/31/2021; 00091458SA, Exp 12/31/2021; 00091458SA, 11821458SB, Exp 6/30/2023."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210742"], "brand_name": ["CHLORTHALIDONE"], "generic_name": ["CHLORTHALIDONE"], "manufacturer_name": ["Dr. Reddy's Laboratories Inc."], "product_ndc": ["43598-719", "43598-720"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORTHALIDONE"], "rxcui": ["197499", "197500"], "spl_id": ["46902081-6a2d-4489-b828-351a33d405b5"], "spl_set_id": ["9e9e9ced-6960-4d2f-bb23-ef8b2435da75"], "package_ndc": ["43598-719-01", "43598-719-10", "43598-720-01", "43598-720-10"], "is_original_packager": [true], "upc": ["0343598720012"], "nui": ["N0000175359", "N0000175420"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide-like Diuretic [EPC]"], "unii": ["Q0MQD1073Q"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0172-2024", "product_description": "CHLORTHALIDONE Tablets, USP,  25MG, 1000 Tablets, Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854 USA; Manufactured For: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA. NDC:  43598-719-10", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 2107329UM", "more_code_info": ""}, {"status": "Ongoing", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA008372"], "brand_name": ["ACTHAR"], "generic_name": ["REPOSITORY CORTICOTROPIN"], "manufacturer_name": ["Mallinckrodt ARD LLC"], "product_ndc": ["63004-8710", "63004-8712", "63004-8711"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "SUBCUTANEOUS"], "substance_name": ["CORTICOTROPIN"], "rxcui": ["309541", "1040025", "2685293", "2685296", "2685298", "2685299"], "spl_id": ["2f3a449b-3b11-4e73-bb44-621c167a0934"], "spl_set_id": ["7b48ddec-e815-45f4-9ca0-5c0daaf56f30"], "package_ndc": ["63004-8710-1", "63004-8710-2", "63004-8712-1", "63004-8712-4", "63004-8711-1", "63004-8711-4"], "is_original_packager": [true], "upc": ["0363004871213"], "nui": ["M0000499", "N0000175941"], "pharm_class_cs": ["Adrenocorticotropic Hormone [CS]"], "pharm_class_epc": ["Adrenocorticotropic Hormone [EPC]"], "unii": ["K0U68Q2TXA"]}, "product_type": "Drugs", "event_id": "93945", "recalling_firm": "Mallinckrodt Hospital Products Inc.", "address_1": "440 Us Highway 22", "address_2": "Ste 302", "postal_code": "08807-2477", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0340-2024", "product_description": "Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-dose vial, Rx only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1", "product_quantity": "8 vials involved in recall (16,479 vials distributed)", "reason_for_recall": "cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.", "recall_initiation_date": "20240206", "center_classification_date": "20240221", "report_date": "20240228", "code_info": "Lot #: 1564-103, Exp 9/30/2024"}, {"status": "Ongoing", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA214313"], "brand_name": ["NOREPINEPHRINE BITARTRATE"], "generic_name": ["NOREPINEPHRINE BITARTRATE"], "manufacturer_name": ["Baxter Healthcare Corporation"], "product_ndc": ["0338-0108", "0338-0112", "0338-0116"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NOREPINEPHRINE BITARTRATE"], "rxcui": ["2475337", "2475340", "2619579"], "spl_id": ["c2f39b23-aa75-473c-951d-dee8ef00ab01"], "spl_set_id": ["6363e9b4-29df-4553-904d-a563e5adda6e"], "package_ndc": ["0338-0112-20", "0338-0108-20", "0338-0116-20"], "is_original_packager": [true], "unii": ["IFY5PE3ZRW"]}, "product_type": "Drugs", "event_id": "93843", "recalling_firm": "Baxter Healthcare Corporation", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0336-2024", "product_description": "Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For Intravenous Infusion Only, 250 mL vial, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015.  Made in Ireland.  NDC:  0338-0108-20", "product_quantity": "13,000 bags", "reason_for_recall": "Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.", "recall_initiation_date": "20240123", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "Lot 23I21G64; Exp. 07/31/2024"}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0383-2024", "product_description": "TRP Natural Eyes Red Eye Relief, Sterile Eye Drops, Homeopathic, 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-158-15.", "product_quantity": "106,704 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: R608, Exp:04-21-2024, R609, Exp: 05-19-2024, R610, Exp: 07-28-2024, R611, Exp: 10-6-2024; R612, Exp: 02-02-2025, R613, Exp: 10-12-2025, R614, Exp: 11-02-2025"}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94145", "recalling_firm": "Optikem International, Inc.", "address_1": "2172 S Jason St", "address_2": "N/A", "postal_code": "80223-4005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed Nationwide in the USA", "recall_number": "D-0377-2024", "product_description": "TRP Eye Twitching Relief, Sterile Eye Drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured for TRP Company, Inc, 1575 Delucchi Lane, Suite # 208, Reno, NV, NDC # 17312-040-15.", "product_quantity": "9,936 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240229", "center_classification_date": "20240312", "report_date": "20240320", "code_info": "Lot #: C303, Exp: 07-27-2025"}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204170"], "brand_name": ["ZOLPIDEM TARTRATE"], "generic_name": ["ZOLPIDEM TARTRATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-307", "47335-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ZOLPIDEM TARTRATE"], "rxcui": ["854880", "854894"], "spl_id": ["4a5c474b-e752-4d01-be37-a66e7c9bf62e"], "spl_set_id": ["0c64bc71-2e7f-4b15-a8e1-acb8de04395f"], "package_ndc": ["47335-307-88", "47335-307-13", "47335-308-88", "47335-308-13"], "is_original_packager": [true], "upc": ["0347335307887", "0347335308884"], "unii": ["WY6W63843K"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0271-2024", "product_description": "Zolpidem Tartrate Extended-Release Tablets, USP 6.25 mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA, NDC 47335-307-88.", "product_quantity": "1220 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #: DNE0892A Exp. 07/31/2026"}, {"status": "Ongoing", "city": "Rangareddy", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93868", "recalling_firm": "NATCO Pharma Limited", "address_1": "Pharma Division, Kothur Village", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0318-2024", "product_description": "Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41", "product_quantity": "4260 bottles", "reason_for_recall": "CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.", "recall_initiation_date": "20240201", "center_classification_date": "20240208", "report_date": "20240214", "code_info": "Lot # 411987 Exp:  05/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206799"], "brand_name": ["VORICONAZOLE"], "generic_name": ["VORICONAZOLE"], "manufacturer_name": ["Lupin Pharmaceuticals,Inc."], "product_ndc": ["43386-038"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VORICONAZOLE"], "rxcui": ["465355"], "spl_id": ["9b8865b7-cdc3-4505-b9ba-b3ab1bf909d6"], "spl_set_id": ["e37525e8-afb4-4583-b2de-af4aab9040d7"], "package_ndc": ["43386-038-60"], "is_original_packager": [true], "nui": ["N0000175487", "M0002083", "N0000182141", "N0000182140", "N0000185504"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "unii": ["JFU09I87TR"]}, "product_type": "Drugs", "event_id": "93934", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "OH, IL, NJ", "recall_number": "D-0337-2024", "product_description": "Voriconazole for Oral Suspension, 40mg/mL, Orange-Flavored, 49g/75mL when reconstituted. Mixing Directions: Tap the bottle to release the powder. Add 50mL of water to the bottle and shake vigorously for 1 minute. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, MD 21202. NDC: 43386-038-60.", "product_quantity": "N/A", "reason_for_recall": "Labeling: Incorrect or Missing Package Insert", "recall_initiation_date": "20240205", "center_classification_date": "20240216", "termination_date": "20241227", "report_date": "20240228", "code_info": "Lot#: S200756; Exp. 10/2024 Lot#: S300218; Exp. 04/2025 Lot#: S300633; Exp. 09/2025"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0306-2024", "product_description": "Lubricant Gel Drops (Carboxymethylcellulose sodium 1.0%), packaged in 0.5 FL OZ (15 mL) bottles, Distributed by: Rite Aid 30 Hunter Lane, Camp Hill, PA 17011, NDC 11822-4540-5", "product_quantity": "7,200 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA040597"], "brand_name": ["BENZONATATE"], "generic_name": ["BENZONATATE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-214"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BENZONATATE"], "rxcui": ["197397"], "spl_id": ["235a2641-ce68-1f9c-e063-6394a90ac8a7"], "spl_set_id": ["9a71725a-64b6-4800-a79c-aa4b2d74d44f"], "package_ndc": ["68084-214-11", "68084-214-01"], "original_packager_product_ndc": ["68382-247"], "nui": ["N0000009010", "N0000175796"], "pharm_class_pe": ["Decreased Tracheobronchial Stretch Receptor Activity [PE]"], "pharm_class_epc": ["Non-narcotic Antitussive [EPC]"], "unii": ["5P4DHS6ENR"]}, "product_type": "Drugs", "event_id": "93778", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "N/A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0257-2024", "product_description": "Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217.  Carton NDC 68084-214-01; Individual Dose NDC 68084-214-11", "product_quantity": "6,344 cartons", "reason_for_recall": "Superpotent drug: Assay results were slightly above specification at the time zero point.", "recall_initiation_date": "20231226", "center_classification_date": "20240119", "report_date": "20240131", "code_info": "Lot # 1014208, Exp Mar/31/2025"}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["MAGNESIUM CITRATE"], "manufacturer_name": ["WALGREEN COMPANY"], "product_ndc": ["0363-0427"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["29f8e1fc-be2e-b603-e063-6394a90a7673"], "spl_set_id": ["effad954-b70d-d8e6-e053-2a95a90acaf7"], "package_ndc": ["0363-0427-98"], "is_original_packager": [true], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "93682", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide.", "recall_number": "D-0228-2024", "product_description": "Walgreens Dye-Free Magnesium Citrate Saline Laxative/Oral Solution, Sugar Free Low Sodium, Grape flavor 10 fl. oz, Distributed by: Walgreen Co, 200 Wilmot Rd, Deerfield, IL 60015, NDC 0363-0427-98.", "product_quantity": "49,716 Bottles", "reason_for_recall": "MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.", "recall_initiation_date": "20231221", "center_classification_date": "20240112", "report_date": "20240124", "code_info": "Lot A80623; Exp. 11/30/2025"}, {"status": "Completed", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021849"], "brand_name": ["OMEPRAZOLE AND SODIUM BICARBONATE"], "generic_name": ["OMEPRAZOLE, SODIUM BICARBONATE"], "manufacturer_name": ["Oceanside Pharmaceuticals"], "product_ndc": ["68682-102", "68682-990", "68682-991", "68682-104"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OMEPRAZOLE", "SODIUM BICARBONATE"], "rxcui": ["616539", "616541", "753557", "753562"], "spl_id": ["342c0d17-867e-d8da-e063-6394a90a3151"], "spl_set_id": ["c26b6893-8264-4d4a-ac7e-1ddda933451e"], "package_ndc": ["68682-990-30", "68682-991-30", "68682-102-30", "68682-104-30"], "is_original_packager": [true], "upc": ["0368682102307", "0368682104301"], "nui": ["N0000175525", "N0000000147", "N0000182140"], "pharm_class_epc": ["Proton Pump Inhibitor [EPC]"], "pharm_class_moa": ["Proton Pump Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "unii": ["KG60484QX9", "8MDF5V39QO"]}, "product_type": "Drugs", "event_id": "93911", "recalling_firm": "Bausch Health Companies, Inc.", "address_1": "400 Somerset Corporate Blvd", "address_2": "", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0355-2024", "product_description": "Omeprazole and Sodium Bicarbonate For Oral Suspension  40mg/1,680mg, This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate, Directions for Use: Empty packet contents into a small cup containing 1 to 2 tablespoons of WATER. DO NOT USE OTHER LIQUIDS OR FOODS. Stir well and drink immediately. Rx Only, Distributed by: Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, Bridgewater, NJ 08807, NDC 68682-991-30.", "product_quantity": "3,600 cartons", "reason_for_recall": "Subpotent Drug: Out of specification for assay", "recall_initiation_date": "20240202", "center_classification_date": "20240228", "report_date": "20240306", "code_info": "Lot #0013R; Exp. 01/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021067"], "brand_name": ["ASMANEX"], "generic_name": ["MOMETASONE FUROATE"], "manufacturer_name": ["Organon LLC"], "product_ndc": ["78206-114", "78206-115"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["MOMETASONE FUROATE"], "rxcui": ["746803", "746804", "746810", "746811", "746812", "746813", "746814", "746815", "790283", "790284"], "spl_id": ["4742e310-f27e-4c57-97d2-29034ed8bea8"], "spl_set_id": ["10b36fb2-6b0d-4f20-b197-3564d6f594b9"], "package_ndc": ["78206-114-03", "78206-114-04", "78206-114-02", "78206-114-01", "78206-114-59", "78206-115-59", "78206-115-01"], "is_original_packager": [true], "unii": ["04201GDN4R"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0169-2024", "product_description": "Asmanex Twisthaler (mometasone furoate inhalation powder, 220 mcg per actuation), 120 Metered Doses, Rx only, Manufactured for: Organon LLC, a subsidiary of Organon & Co., Jersey City, NJ 07302; Manufactured by: MSD International GmbH (Singapore Branch) Singapore 638030, Singapore. NDC: 78206-114-01", "product_quantity": "3 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch U027458", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA215307"], "brand_name": ["DIGOXIN"], "generic_name": ["DIGOXIN"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "product_ndc": ["70954-200", "70954-201", "70954-202"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIGOXIN"], "rxcui": ["197604", "197606", "245273"], "spl_id": ["ee465d1a-f5ee-477b-b20e-3ce8705e7472"], "spl_set_id": ["dba3b3f7-3ff2-4996-8653-b0e54a398bf9"], "package_ndc": ["70954-201-10", "70954-201-20", "70954-202-10", "70954-202-20", "70954-200-10"], "is_original_packager": [true], "upc": ["0370954201106", "0370954201205", "0370954202103", "0370954200109"], "nui": ["N0000175568", "M0003451"], "pharm_class_epc": ["Cardiac Glycoside [EPC]"], "pharm_class_cs": ["Cardiac Glycosides [CS]"], "unii": ["73K4184T59"]}, "product_type": "Drugs", "event_id": "94132", "recalling_firm": "Novitium Pharma LLC", "address_1": "70 Lake Dr", "address_2": "", "postal_code": "08520-5321", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0389-2024", "product_description": "Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20", "product_quantity": "3,940 1000-count bottles", "reason_for_recall": "Cross Contamination with Other Products:(mycophenolate mofetil).", "recall_initiation_date": "20240304", "center_classification_date": "20240315", "termination_date": "20250321", "report_date": "20240327", "code_info": "Lot #: M23172A, Exp 01/31/2025", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091567"], "brand_name": ["FEXOFENADINE HYDROCHLORIDE"], "generic_name": ["FEXOFENADINE HYDROCHLORIDE"], "manufacturer_name": ["OHM LABORATORIES INC.", "CVS PHARMACY, INC"], "product_ndc": ["51660-998", "51316-800"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["FEXOFENADINE HYDROCHLORIDE"], "rxcui": ["997420"], "spl_id": ["091c0633-b5d5-462a-8aa0-36ae245dbbbc", "e6bae65e-9f41-4976-bebd-c14e86da14cb"], "spl_set_id": ["1a1afa95-570d-456e-b436-a0fcfaf68517", "7bc13851-291a-4582-8261-13c5022fbdd1"], "package_ndc": ["51660-998-30", "51660-998-55", "51316-800-90", "51316-800-70", "51316-800-45", "51316-800-30", "51316-800-15", "51316-800-08"], "is_original_packager": [true], "unii": ["2S068B75ZU"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0273-2024", "product_description": "Fexofenadine Hydrochloride Tablets, USP 180mg, Antihistamine, Allergy, 24 hour, a) 30 Tablets per bottle, NDC 51660-998-30; Distributed by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Made in India, b) 45 Tablets per bottle, NDC 51316-800-45; Distributed by: CVS Pharmacy, Inc., Woonsocket, RI 02895, Made in India, c) 150 Tablets per bottle, NDC 51660-998-55, Distributed by: Ohm Laboratories Inc., New Brunswick, NJ 08901, Made in India.", "product_quantity": "54,504 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #s:  a) DNE0792A Exp. 06/31/2025; DNE1027A Exp. 08/31/2025. b) DNE0793A Exp. 06/31/2025. c) DNE0789A, DNE0790A, DNE0791A Exp. 06/2025, DNE1026A Exp. 08/31/025."}, {"status": "Completed", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93928", "recalling_firm": "Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company", "address_1": "660 White Plains Rd Ste 250", "address_2": "N/A", "postal_code": "10591-5171", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed nationwide and to 4 foreign accounts. Guaynabo, Puerto Rico; Georgetown, Guyana; Baghdad, Iraq; Accra, Ghana.", "recall_number": "D-0346-2024", "product_description": "TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid, NET WT 4.5 oz. (128 g) cans, Distributed by: Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY 10591 UPC 3 63736 81961 3", "product_quantity": "59,644 cans", "reason_for_recall": "Chemical Contamination; presence of benzene.", "recall_initiation_date": "20240201", "center_classification_date": "20240222", "report_date": "20240228", "code_info": "Lot #  0H50545, Exp. date 07/31/24; 1G50645, Exp. date 06/30/25"}, {"status": "Ongoing", "city": "Kansas City", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93808", "recalling_firm": "Neptune Resources, LLC", "address_1": "1324 W 12th St Fl 5", "address_2": "N/A", "postal_code": "64101-1343", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0333-2024", "product_description": "Neptune's Fix, Tianeptine Elixir, Fast Acting, 0.338 fl oz (10 mL) bottle, Distributed By Neptune Resources, LLC, 30 N. Gould Street, Ste R, Sheridan, WY 82801.", "product_quantity": "1,000,000 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.", "recall_initiation_date": "20240112", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "All lots"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA086242"], "brand_name": ["HYDRALAZINE HYDROCHLORIDE"], "generic_name": ["HYDRALAZINE HYDROCHLORIDE"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-447"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDRALAZINE HYDROCHLORIDE"], "rxcui": ["905199"], "spl_id": ["13a2cf75-5816-2d86-e063-6394a90a0cc2"], "spl_set_id": ["53908945-540f-4d34-8f0a-b4a87676634e"], "package_ndc": ["68084-447-11", "68084-447-01"], "original_packager_product_ndc": ["23155-001"], "unii": ["FD171B778Y"]}, "product_type": "Drugs", "event_id": "93936", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0320-2024", "product_description": "HydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217.  NDC Carton: 68084-447-01;  NDC Unit Dose: 68084-447-11", "product_quantity": "2,850 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of Specification (OOS) result in the repackaged product for Related Compounds (Impurities) at the 6-month time point.", "recall_initiation_date": "20240201", "center_classification_date": "20240208", "report_date": "20240214", "code_info": "Lot #: 1012275, Exp 02/28/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {"application_number": ["M018"], "brand_name": ["DRY EYE RELIEF"], "generic_name": ["POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL"], "manufacturer_name": ["CARDINAL HEALTH 110, LLC. DBA LEADER"], "product_ndc": ["70000-0088"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["POLYETHYLENE GLYCOL 400", "PROPYLENE GLYCOL"], "rxcui": ["895753"], "spl_id": ["424cccfb-27a9-43c8-9793-34bc5ddcb882"], "spl_set_id": ["f8da3af5-9172-4023-be82-0fd5bd891616"], "package_ndc": ["70000-0088-1"], "is_original_packager": [true], "unii": ["B697894SGQ", "6DC9Q167V3"]}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0295-2024", "product_description": "Leader brand Dry Eye Relief (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%) packaged in 0.33 FL OZ (10 mL) bottles, Distributed by Cardinal Health Dublin, Ohio 43017, NDC 70000-0088-1", "product_quantity": "12,960 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}]